EXOSF Stock Chart & Stats
Currently, no data available
Please return soon. This page is being updated.
Bulls Say, Bears Say
Bulls Say
Consistent Revenue GrowthSustained top-line growth through 2025 signals durable product demand and successful penetration in defense, industrial and scientific markets. Multi-year revenue expansion improves scale economics, supports ongoing R&D and qualification cycles, and increases visibility into future order flows.
Improved Leverage And Equity BaseMaterial deleveraging over several years strengthens the balance sheet and financial flexibility. A sizeable equity base versus debt reduces refinancing risk, lowers interest-rate sensitivity and gives management more room to invest in product development or absorb cyclical dips without urgent external funding.
High Operating Profitability And Cash GenerationSustained high EBITDA margins coupled with robust operating cash flow indicate structural operating efficiency in specialized photonics. Strong margins create capacity for R&D and customer qualification programs while positive cash generation supports capex, working capital and gradual debt reduction over time.
Bears Say
Sharp Gross-margin CompressionA dramatic drop in gross margin suggests structural mix shifts, pricing pressure or step-up in input costs that materially erode core profitability. Such compression risks undermining operating leverage, reduces funds available for reinvestment, and makes earnings more sensitive to competitive or supply-side shocks.
Weaker Free-cash-flow ConversionDeclining FCF and worsening conversion versus net income indicate volatility in cash generation, possibly from higher reinvestment or working-capital pressure. This reduces the company's ability to self-fund growth, slows debt paydown, and increases reliance on external financing in adverse periods.
Modest Net Margins And Margin VolatilityAlthough profitability returned after earlier losses, net margins are modest and provide limited cushioning against cost inflation or revenue softness. Combined with margin volatility, this constrains retained earnings for strategic investments and heightens sensitivity to cyclical or competitive headwinds.
Exosens News
EXOSF FAQ
What was Exosens’s price range in the past 12 months?
Currently, no data Available
What is Exosens’s market cap?
Exosens’s market cap is $3.54B.
When is Exosens’s upcoming earnings report date?
Exosens’s upcoming earnings report date is Mar 08, 2027 which is in 192 days.
How were Exosens’s earnings last quarter?
Exosens released its earnings results on Jul 28, 2026. The company reported $0.35 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
Is Exosens overvalued?
According to Wall Street analysts Exosens’s price is currently Undervalued.
Does Exosens pay dividends?
Exosens does not currently pay dividends.
What is Exosens’s EPS estimate?
Exosens’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Exosens have?
Exosens has 50,936,750 shares outstanding.
What happened to Exosens’s price movement after its last earnings report?
Exosens reported an EPS of $0.35 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of Exosens?
Currently, no hedge funds are holding shares in EXOSF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Exosens
Exosens specializes in the development, production, and global distribution of advanced electro-optical technologies. Its core expertise lies in amplification, detection, and imaging solutions, catering to markets across France, the rest of Europe, North America, Asia, Oceania, and Africa, as well as other international territories. The company's extensive product portfolio features image intensifier tubes; a diverse array of cameras covering ultraviolet, short-wave, long-wave, visible-near infrared, and mid-wave infrared spectra; and enhanced vision equipment. Exosens further provides ion, electron, scintillation, and single photon detection products; X-ray components, neutronic imaging systems, and image intensifiers tailored for scientific applications; alongside gamma and neutron detectors, and mineral insulated extensions. Additionally, it supplies power tubes, microwave devices, and airborne solutions for methane detection. Operating under prominent brands including Photonis, Xenics, Telops, and El-Mul, Exosens serves vital sectors such as defense and surveillance, industrial research and control, life science and environmental monitoring, and the nuclear industry. Established in 1937 and headquartered in Mérignac, France, Exosens functions as a subsidiary of HLD Europe S.C.A.
EXOSF Stock 12 Month Forecast
Average Price Target
$85.34
▲(65.55% Upside)
Ownership Overview
―
Insiders
5.04% Mutual Funds
― Other Institutional Investors
88.39% Public Companies and
Individual Investors